Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Stroke
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Stroke
    Migraine and cardiovascular disease: systematic review and meta-analysis - (BMJ)
    TopAbstracts in Stroke 10/29/2009 - (DGNews)
    Further Evidence Backs Extension of Treatment Window for Stroke to 4.5 Hours - (DGNews)
    C-Reactive Protein May Predict MI and Early Death, But Not Stroke - (DGNews)
    Diagnosis of Cardiovascular Disease Associated With Risk of Subsequent Hip Fracture - (DGNews)

    News archive

     Recent webcasts/CME - Stroke
    • The Evolving Role of Antiplatelet Therapy for Atrial Fibrillation: Highlights From the ACC Scientific Sessions 2009
    • Current Standard of Care for Stroke Prevention in Patients With Atrial Fibrillation (AF)
    • Aneurysm Rupture and Subarachnoid Hemorrhage Cerebral Revascularization: The Role of EC-IC Bypass in the 21st Century
      Stenting for Intracranial Atherosclerosis
      Diffusion-Weighted Imaging: Not All That Glitters Is Gold

      Webcasts/CME archive

       Recent cases - Stroke
        Adult Cor Triatriatum Presenting as Cardioembolic Stroke
        Pure Sensory Stroke Form Compression of Putaminal Hemorrhage: A Case Report
        An Echocardiographic-Confirmed Case of Atrial Myxoma Causing Cerebral Embolic Ischemic Stroke: A Case Report
        Diffusion-Negative MRI in Acute Ischemic Stroke: A Case Report
        F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for the Diagnosis of Takayasu's Arteritis in Stroke: A Case Report

        Cases archive
          




        my personal edition > stroke > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Levodopa And Physiotherapy Combined Aids Stroke Recovery

        A DGReview of :"Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study"
        Lancet

        09/06/2001
        By Harvey McConnell


        A combination of the neurotransmitter precursor levodopa and physiotherapy appears to improve motor recovery for stroke patients.

        Dr. Klaus Scheidtmann and colleagues at the Neurological Hospital Bad Aibling, Bad Aibling, Germany, believe that because of minimal side effects, levodopa could be a possible add-on during stroke rehabilitation.

        He and his colleagues point out that physiotherapy used to be the only way of improving motor function in patients with hemiplegia. However, administration of amphetamines in addition to exercise improves motor recovery in animal models, probably by increasing the concentration of norepinephrine in the central nervous system.

        Their trial was designed to see whether levodopa could enhance the efficacy of physiotherapy after hemiplegia.

        Systemic administration of norepinephrine might have potentially dangerous cardiovascular side effects, though no clinically important adverse events have been recorded, the clinicians said. However, physical and psychological dependence cannot be excluded, and this restricts its use.

        To increase norepinephrine, but avoid these effects, levodopa is given orally; it is then metabolised to dopamine in the brain and converted to norepinephrine at a rate of up to 5 percent. In the periphery, metabolism is blocked by a decarboxylase inhibitor, which does not cross the blood-brain barrier.

        Dr. Scheidtmann and colleagues enrolled 53 primary stroke patients in a prospective, randomised study. For the first three weeks, patients received single doses of 100 mg levodopa or placebo daily in combination with physiotherapy. For the second three weeks, patients had only physiotherapy.

        Motor function was assessed every week by Rivermead motor assessment (RMA).

        Motor recovery was substantially improved after three weeks in patients given levodopa (RMA improved by 6.4 points) compared with placebo (RMA 4.1) Result was independent of initial degree of impairment. The advantage of the levodopa group was maintained three weeks after levodopa administration was stopped.

        At the end of the study, the total RMA score gain for the levodopa group was 8.2 points compared with 5.7 in the placebo group.

        Dr. Friedemann Müller, one of the investigators in the study, said of the results: "A single dose of levodopa was well tolerated and, when given in combination with physiotherapy, was found to enhance motor recovery in patients with hemiplegia.

        "This trend should be confirmed, and we need to establish long-term ceiling effects, which our short observation period did not allow us to judge. We should also ascertain to what extent the lesion size and amount of levodopa affect enhanced functional recovery."
        Lancet 2001; 358: 787-90. "Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send